Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vuity for presbyopia retinal and choroidal safety crossover study
ACTRN12624000383561Phase 4Recruiting
- Sponsor
- The University of Auckland
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of pilocarpine in presbyopia (2 arms), sponsored by The University of Auckland. Primary endpoint: Change in subfoveal choroidal thickness. Started Aug 2025; status: recruiting.
02
Drugs
pilocarpine
03
Conditions
presbyopia
Beyond the preview
Go deeper on ACTRN12624000383561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624000383561.